Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma

In papillary thyroid cancer (PTC) patients, cervical lymph node metastases are common, which disseminate sequentially from the central neck to the lateral neck. However, there is also a chaotic pattern of lymph node metastasis occasionally. In this study, we summarized 653 PTC patients who underwent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrine pathology 2020-03, Vol.31 (1), p.67-76
Hauptverfasser: Feng, Jia-Wei, Qin, An-Cheng, Ye, Jing, Pan, Hua, Jiang, Yong, Qu, Zhen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 76
container_issue 1
container_start_page 67
container_title Endocrine pathology
container_volume 31
creator Feng, Jia-Wei
Qin, An-Cheng
Ye, Jing
Pan, Hua
Jiang, Yong
Qu, Zhen
description In papillary thyroid cancer (PTC) patients, cervical lymph node metastases are common, which disseminate sequentially from the central neck to the lateral neck. However, there is also a chaotic pattern of lymph node metastasis occasionally. In this study, we summarized 653 PTC patients who underwent thyroidectomy and central lymph node dissection with or without lateral lymph node dissection from two hospitals to investigate the pattern and risk factors of lateral lymph node metastasis (LLNM) and skip metastasis. LLNM was significantly associated tumor size > 1 cm, presence of extrathyroidal extension, tumors in the upper-lateral pole, and the number of metastatic lymph nodes in the central compartment. The frequency of skip metastasis was 22.5% (20 of 89 patients). Multivariate analyses showed tumor size ≤ 1 cm, and tumors in the upper-lateral pole were separately and independently associated with the risk of skip metastasis. Presence of LLNM affected the recurrence-free survival (RFS). RFS did not show the significantly difference between patients with LLNM and skip metastasis. Despite the low incidence of skip metastasis, attention should be paid to the possibility of LLNM even in the absence of central lymph node metastases. Besides, for patients with risk factors of LLNM or skip metastasis, detailed preoperative examination for the lateral compartment, especially the level III, is essential.
doi_str_mv 10.1007/s12022-019-09599-w
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2325298579</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2362191956</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-b715dbd6e78b02a3998702baa6112dc9e0120f7e9ab4de2d5b2cfa5be81268d03</originalsourceid><addsrcrecordid>eNqNkVFrFTEQhYMotlb_gA8S8EWQrZOk2WweZbEq3GrB-rxkk9k29W6yJrte7r9vdGsrPogQSCZ8Z5gzh5DnDI4ZgHqTGQfOK2C6Ai21rnYPyCGTspSg1cPyhpO6ElrVB-RJztcATADwx-RAsIY3shGH5PI8ofN29j-Qnho7x5TpEBPdmBmT2dLNfpyu6KfokJ7hbHI5PlMTHP3yzU9__vlAz83kt1uT9vTiap-id7Q1yfoQR_OUPBrMNuOz2_uIfD19d9F-qDaf339s324qK5Scq14x6XpXo2p64EZo3SjgvTE1Y9xZjVA8Dwq16U8ccid7bgcje2wYrxsH4oi8WvtOKX5fMM_d6LPFMlXAuOSOCy65bqTSBX35F3odlxTKdIWqOdNMy7pQfKVsijknHLop-bF47Bh0P2Po1hi6EkP3K4ZuV0Qvblsv_YjuTvJ77wVoVmCHfRyy9Rgs3mEAIJkuCylxAYPWz2b2MbRxCXORvv5_aaHFSudChEtM9yb_Mf8NliK0YQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2362191956</pqid></control><display><type>article</type><title>Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma</title><source>SpringerLink Journals - AutoHoldings</source><creator>Feng, Jia-Wei ; Qin, An-Cheng ; Ye, Jing ; Pan, Hua ; Jiang, Yong ; Qu, Zhen</creator><creatorcontrib>Feng, Jia-Wei ; Qin, An-Cheng ; Ye, Jing ; Pan, Hua ; Jiang, Yong ; Qu, Zhen</creatorcontrib><description>In papillary thyroid cancer (PTC) patients, cervical lymph node metastases are common, which disseminate sequentially from the central neck to the lateral neck. However, there is also a chaotic pattern of lymph node metastasis occasionally. In this study, we summarized 653 PTC patients who underwent thyroidectomy and central lymph node dissection with or without lateral lymph node dissection from two hospitals to investigate the pattern and risk factors of lateral lymph node metastasis (LLNM) and skip metastasis. LLNM was significantly associated tumor size &gt; 1 cm, presence of extrathyroidal extension, tumors in the upper-lateral pole, and the number of metastatic lymph nodes in the central compartment. The frequency of skip metastasis was 22.5% (20 of 89 patients). Multivariate analyses showed tumor size ≤ 1 cm, and tumors in the upper-lateral pole were separately and independently associated with the risk of skip metastasis. Presence of LLNM affected the recurrence-free survival (RFS). RFS did not show the significantly difference between patients with LLNM and skip metastasis. Despite the low incidence of skip metastasis, attention should be paid to the possibility of LLNM even in the absence of central lymph node metastases. Besides, for patients with risk factors of LLNM or skip metastasis, detailed preoperative examination for the lateral compartment, especially the level III, is essential.</description><identifier>ISSN: 1046-3976</identifier><identifier>EISSN: 1559-0097</identifier><identifier>DOI: 10.1007/s12022-019-09599-w</identifier><identifier>PMID: 31828583</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Biopsy ; Endocrinology ; Endocrinology &amp; Metabolism ; Life Sciences &amp; Biomedicine ; Lymph nodes ; Lymphatic system ; Medicine ; Medicine &amp; Public Health ; Metastases ; Metastasis ; Oncology ; Papillary thyroid cancer ; Papillary thyroid carcinoma ; Pathology ; Risk factors ; Science &amp; Technology ; Thyroid cancer ; Thyroidectomy ; Tumors</subject><ispartof>Endocrine pathology, 2020-03, Vol.31 (1), p.67-76</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019</rights><rights>Endocrine Pathology is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>46</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000519375300010</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c375t-b715dbd6e78b02a3998702baa6112dc9e0120f7e9ab4de2d5b2cfa5be81268d03</citedby><cites>FETCH-LOGICAL-c375t-b715dbd6e78b02a3998702baa6112dc9e0120f7e9ab4de2d5b2cfa5be81268d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12022-019-09599-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12022-019-09599-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31828583$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Feng, Jia-Wei</creatorcontrib><creatorcontrib>Qin, An-Cheng</creatorcontrib><creatorcontrib>Ye, Jing</creatorcontrib><creatorcontrib>Pan, Hua</creatorcontrib><creatorcontrib>Jiang, Yong</creatorcontrib><creatorcontrib>Qu, Zhen</creatorcontrib><title>Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma</title><title>Endocrine pathology</title><addtitle>Endocr Pathol</addtitle><addtitle>ENDOCR PATHOL</addtitle><addtitle>Endocr Pathol</addtitle><description>In papillary thyroid cancer (PTC) patients, cervical lymph node metastases are common, which disseminate sequentially from the central neck to the lateral neck. However, there is also a chaotic pattern of lymph node metastasis occasionally. In this study, we summarized 653 PTC patients who underwent thyroidectomy and central lymph node dissection with or without lateral lymph node dissection from two hospitals to investigate the pattern and risk factors of lateral lymph node metastasis (LLNM) and skip metastasis. LLNM was significantly associated tumor size &gt; 1 cm, presence of extrathyroidal extension, tumors in the upper-lateral pole, and the number of metastatic lymph nodes in the central compartment. The frequency of skip metastasis was 22.5% (20 of 89 patients). Multivariate analyses showed tumor size ≤ 1 cm, and tumors in the upper-lateral pole were separately and independently associated with the risk of skip metastasis. Presence of LLNM affected the recurrence-free survival (RFS). RFS did not show the significantly difference between patients with LLNM and skip metastasis. Despite the low incidence of skip metastasis, attention should be paid to the possibility of LLNM even in the absence of central lymph node metastases. Besides, for patients with risk factors of LLNM or skip metastasis, detailed preoperative examination for the lateral compartment, especially the level III, is essential.</description><subject>Biopsy</subject><subject>Endocrinology</subject><subject>Endocrinology &amp; Metabolism</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Lymph nodes</subject><subject>Lymphatic system</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Oncology</subject><subject>Papillary thyroid cancer</subject><subject>Papillary thyroid carcinoma</subject><subject>Pathology</subject><subject>Risk factors</subject><subject>Science &amp; Technology</subject><subject>Thyroid cancer</subject><subject>Thyroidectomy</subject><subject>Tumors</subject><issn>1046-3976</issn><issn>1559-0097</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkVFrFTEQhYMotlb_gA8S8EWQrZOk2WweZbEq3GrB-rxkk9k29W6yJrte7r9vdGsrPogQSCZ8Z5gzh5DnDI4ZgHqTGQfOK2C6Ai21rnYPyCGTspSg1cPyhpO6ElrVB-RJztcATADwx-RAsIY3shGH5PI8ofN29j-Qnho7x5TpEBPdmBmT2dLNfpyu6KfokJ7hbHI5PlMTHP3yzU9__vlAz83kt1uT9vTiap-id7Q1yfoQR_OUPBrMNuOz2_uIfD19d9F-qDaf339s324qK5Scq14x6XpXo2p64EZo3SjgvTE1Y9xZjVA8Dwq16U8ccid7bgcje2wYrxsH4oi8WvtOKX5fMM_d6LPFMlXAuOSOCy65bqTSBX35F3odlxTKdIWqOdNMy7pQfKVsijknHLop-bF47Bh0P2Po1hi6EkP3K4ZuV0Qvblsv_YjuTvJ77wVoVmCHfRyy9Rgs3mEAIJkuCylxAYPWz2b2MbRxCXORvv5_aaHFSudChEtM9yb_Mf8NliK0YQ</recordid><startdate>20200301</startdate><enddate>20200301</enddate><creator>Feng, Jia-Wei</creator><creator>Qin, An-Cheng</creator><creator>Ye, Jing</creator><creator>Pan, Hua</creator><creator>Jiang, Yong</creator><creator>Qu, Zhen</creator><general>Springer US</general><general>Humana Press Inc</general><general>Springer Nature B.V</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20200301</creationdate><title>Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma</title><author>Feng, Jia-Wei ; Qin, An-Cheng ; Ye, Jing ; Pan, Hua ; Jiang, Yong ; Qu, Zhen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-b715dbd6e78b02a3998702baa6112dc9e0120f7e9ab4de2d5b2cfa5be81268d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biopsy</topic><topic>Endocrinology</topic><topic>Endocrinology &amp; Metabolism</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Lymph nodes</topic><topic>Lymphatic system</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Oncology</topic><topic>Papillary thyroid cancer</topic><topic>Papillary thyroid carcinoma</topic><topic>Pathology</topic><topic>Risk factors</topic><topic>Science &amp; Technology</topic><topic>Thyroid cancer</topic><topic>Thyroidectomy</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feng, Jia-Wei</creatorcontrib><creatorcontrib>Qin, An-Cheng</creatorcontrib><creatorcontrib>Ye, Jing</creatorcontrib><creatorcontrib>Pan, Hua</creatorcontrib><creatorcontrib>Jiang, Yong</creatorcontrib><creatorcontrib>Qu, Zhen</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feng, Jia-Wei</au><au>Qin, An-Cheng</au><au>Ye, Jing</au><au>Pan, Hua</au><au>Jiang, Yong</au><au>Qu, Zhen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma</atitle><jtitle>Endocrine pathology</jtitle><stitle>Endocr Pathol</stitle><stitle>ENDOCR PATHOL</stitle><addtitle>Endocr Pathol</addtitle><date>2020-03-01</date><risdate>2020</risdate><volume>31</volume><issue>1</issue><spage>67</spage><epage>76</epage><pages>67-76</pages><issn>1046-3976</issn><eissn>1559-0097</eissn><abstract>In papillary thyroid cancer (PTC) patients, cervical lymph node metastases are common, which disseminate sequentially from the central neck to the lateral neck. However, there is also a chaotic pattern of lymph node metastasis occasionally. In this study, we summarized 653 PTC patients who underwent thyroidectomy and central lymph node dissection with or without lateral lymph node dissection from two hospitals to investigate the pattern and risk factors of lateral lymph node metastasis (LLNM) and skip metastasis. LLNM was significantly associated tumor size &gt; 1 cm, presence of extrathyroidal extension, tumors in the upper-lateral pole, and the number of metastatic lymph nodes in the central compartment. The frequency of skip metastasis was 22.5% (20 of 89 patients). Multivariate analyses showed tumor size ≤ 1 cm, and tumors in the upper-lateral pole were separately and independently associated with the risk of skip metastasis. Presence of LLNM affected the recurrence-free survival (RFS). RFS did not show the significantly difference between patients with LLNM and skip metastasis. Despite the low incidence of skip metastasis, attention should be paid to the possibility of LLNM even in the absence of central lymph node metastases. Besides, for patients with risk factors of LLNM or skip metastasis, detailed preoperative examination for the lateral compartment, especially the level III, is essential.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>31828583</pmid><doi>10.1007/s12022-019-09599-w</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1046-3976
ispartof Endocrine pathology, 2020-03, Vol.31 (1), p.67-76
issn 1046-3976
1559-0097
language eng
recordid cdi_proquest_miscellaneous_2325298579
source SpringerLink Journals - AutoHoldings
subjects Biopsy
Endocrinology
Endocrinology & Metabolism
Life Sciences & Biomedicine
Lymph nodes
Lymphatic system
Medicine
Medicine & Public Health
Metastases
Metastasis
Oncology
Papillary thyroid cancer
Papillary thyroid carcinoma
Pathology
Risk factors
Science & Technology
Thyroid cancer
Thyroidectomy
Tumors
title Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T13%3A54%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictive%20Factors%20for%20Lateral%20Lymph%20Node%20Metastasis%20and%20Skip%20Metastasis%20in%20Papillary%20Thyroid%20Carcinoma&rft.jtitle=Endocrine%20pathology&rft.au=Feng,%20Jia-Wei&rft.date=2020-03-01&rft.volume=31&rft.issue=1&rft.spage=67&rft.epage=76&rft.pages=67-76&rft.issn=1046-3976&rft.eissn=1559-0097&rft_id=info:doi/10.1007/s12022-019-09599-w&rft_dat=%3Cproquest_pubme%3E2362191956%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2362191956&rft_id=info:pmid/31828583&rfr_iscdi=true